Age-related macular degeneration is a common cause of blindness, but adding some static noise to a patient’s vision can ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a ...

Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

Gene therapy for neovascular age-related macular degeneration is linked to positive anatomical changes, but variable visual outcomes.

Researchers in the WashU Medicine Department of Ophthalmology & Visual Sciences have discovered key neuroprotective genes ...

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...

As the technician puts me through a battery of diagnostic tests, with red, pulsating lights searing into both eyeballs, I ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...

Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

Ophthalmoscopy is more than just shining a light into the eye—it’s a window into a patient’s overall health. With the right skills, clinicians can detect sight‑threatening and systemic diseases early.